Biotech Ethics BLOG
This blog is about ethical issues in the biotechnology industry. That includes all 3 main areas of that industry: health biotech, food biotech, and industrial biotech. (The last two are particularly important, and don't get enough attention.)
Unlike my Business Ethics Blog, this one will focus on aggregating information, rather than offering much commentary.
Links:
Email Chris
EthicsWeb Bookstore
The Business Ethics Blog (by Chris MacDonald)
The Research Ethics Blog (by Nancy Walton and Chris MacDonald)
Genethics.ca (by Bryn Williams-Jones)
Ethics of Complementary & Alternative MedicinePages on this Site:
Ethics for the Biotech Industry (my scholarly research)-
Recent Posts
Archives
Author Archives: Chris MacDonald
Should Human Cloning Be Permitted?
Over a decade ago, I wrote a short piece called “Yes, Human Cloning Should Be Permitted,” published in the Annals of the Royal College of Physicians and Surgeons of Canada. The piece was a response to an earlier article, by … Continue reading
Posted in cloning, ethics
4 Comments
Cloned Horses Can Now Compete
The International Federation for Equestrian Sports (Fédération Équestre Internationale, or FEI) has announced a reversal of its previous decision to ban cloned horses from competition. The FEI’s statment, quoted here, includes the following: “The FEI will not forbid participation of … Continue reading
Posted in cloning, ethics, genes, sport
Leave a comment
Pausing Bird Flu Studies
Breaking news, from Nature: the principle investigators of the recent avian flu transmission studies (along with a couple of dozen co-authors) have publicly vowed to “pause” their research for 60 days. What’a really interesting, though, are their reasons. They want … Continue reading
Posted in dual-use, ethics, health, regulation, risk, virology
Leave a comment
Flu Research and the Pursuit of Deadly Knowledge
One of the most fundamental ethical questions facing the world of science and technology has to do with whether some knowledge is so dangerous that it simply ought not be sought. That, essentially, is the question posed by recent research … Continue reading
Posted in Uncategorized
Leave a comment
GM Alfalfa: “Approved” or “Deregulated”?
The US Department of Agriculture has issued a decision allowing widespread planting of genetically modified alfalfa. See this article, by Andrew Pollack for the NYT: U.S. Approves Genetically Modified Alfalfa Agriculture Secretary Tom Vilsack announced on Thursday that he would … Continue reading
Posted in agriculture, GMO, regulation
Leave a comment
Biofuels Underwhelm
A new study has confirmed what common sense already made seem likely, according to this story by Dina Fine Maron for the NYT: Biofuels of No Benefit to Military — RAND A new analysis presented to Congress yesterday paints a … Continue reading
Posted in agriculture, industrial biotechnology
Leave a comment
Canada’s Proposed “Bill C-474”
A “private members bill” currently before Canada’s parliament will, if passed, require that “an analysis of potential harm to export markets be conducted before the sale of any new genetically engineered seed is permitted” in Canada. (FYI, a bill that … Continue reading
Posted in agriculture, GMO, regulation, risk
8 Comments
Unethical Lizard
Is this lizard unethical? From National Geographic, see the Self-Cloning Lizard. According to National Geo, …the newfound Leiolepis ngovantrii is no run-of-the-mill reptile—the all-female species reproduces via cloning, without the need for male lizards. Since so many people apparently think … Continue reading
Posted in cloning, ethics
Leave a comment
Synthetic Biology: Ready, Set, Go!
By Andrew Pollack, for the NYT: U.S. Bioethics Commission Gives Green Light to Synthetic Biology The president’s bioethics commission says there is no need to temporarily halt research or to impose new regulations on the controversial new field known as … Continue reading
Posted in ethics, regulation, synthetic biology
Leave a comment
Ethics, Policy, and Synthetic Biology
By Jef Akst, writing for The Scientist: Q&A: Ethics chair on synthetic biology The Scientist spoke with chair Amy Gutmann, president of the University of Pennsylvania, about the commission’s conclusions that, despite the potential risks of creating synthetic organisms, the … Continue reading
Posted in ethics, regulation, risk, synthetic biology
Leave a comment
Biotech Ethics 